schwein

Transgenic pigs from the United States for human consumption?

In the United States, the Food Safety Authority (FDA) has recently approved genetically modified pigs for human consumption. DP members Gusty Graas and André Bauler ask the Minister for Health and the Minister for Agriculture what they think about the use of these pigs in Europe for pharmaceutical or food production.

« La Food and Drug Administration (FDA), régulateur de santé américain, vient d’approuver le premier cochon génétiquement modifié pour l’alimentation humaine et les usages médicaux. Le cochon, nommé GalSafe, va pouvoir non seulement être consommé en tant que viande mais aussi être utilisé pour la production de produits pharmaceutiques ou pour la production « d’organes de remplacement ».

Même si le premier objectif est de développer des produits médicaux qui ne produiront pas d’allergies, une commercialisation de la viande de cochon GalSafe pourrait être envisagée prochainement. En tout cas, la FDA a d’ores et déjà certifié que cette viande est propre à la consommation. 

Dans ce contexte, nous aimerions poser les questions suivantes à Madame la Ministre de la Santé et à Monsieur le Ministre de l’Agriculture, de la Viticulture et du Développement rural :

– Quel est l’avis de Madame la Ministre concernant l’utilisation de ces cochons à des fins de recherche et de production de médicaments ?

– Est-ce que ces cochons peuvent être utilisés à des fins scientifiques en Europe ?

– Est-ce que des médicaments créés sur base de ce cochon pourront être autorisés sur le marché européen ?

– Quel est l’avis de Monsieur le Ministre concernant l’utilisation de ces cochons au service de l’alimentation humaine ?

– Sachant que l’Union européenne interdit l’élevage d’animaux transgéniques, des produits transformés à base de ces cochons pourraient-ils néanmoins être autorisés sur le marché européen ? »

Answer

The use of genetically modified pigs for scientific purposes is not prohibited in the EU, however, there are a number of requirements that must be met in order to obtain a corresponding authorization. Thus, e.g. the project has to be scientifically justified. In Luxembourg, pigs are not used for scientific purposes. As far as medicines based on genetically engineered animals are concerned, these can also be used in the EU as long as they are authorized by the EMA. Finally, the precautionary principle should be respected with regard to the consumption of such animals. In addition to the fact that food safety must be guaranteed, the production of meat from transgenic animals must also be of interest in relation to normal meat before it can be approved as food.

Would you like this parliamentary question to be translated into English?

Share:

Facebook
Twitter
LinkedIn
Email
WhatsApp

More parliamentary questions

How many doctors work in the north of the country?

In the north of the country, citizens often have to travel long distances to get to a clinic or medical centre.
DP MPs André Bauler and Gilles Baum asked the Minister for Health, among other things, how many GPs and specialists work in the north of the country, what the age pyramid is for doctors and when a second medical centre might open in the north.

read more...

How many women are released from work during pregnancy?

Labour law stipulates that pregnant women may not take on certain tasks at work. The law therefore provides for an adjustment of the workplace or a transfer to another position. If neither is possible, the woman must be released from work.
DP MPs Corinne Cahen and Carole Hartmann wanted to know from the Minister of Health, among other things, how many women are exempted per sector, how often an employer has objected to a dispensation and on the basis of which specific criteria occupational physicians decide on a dispensation.

read more...

Should the LNS and private laboratories work closer together on biopsies?

The LNS, which has a monopoly in this area, has taken a number of measures to counteract the long waiting times for the evaluation of biopsies.
DP MPs Mandy Minella and Dr Gérard Schockmel have asked the Minister of Health what impact these measures have had on waiting times and whether greater cooperation with private laboratories should be considered in order to further reduce waiting times.

read more...

No more reimbursement for dermatoscopic photos?

As part of a dermatologist’s examination, photos can be taken of suspicious skin areas where there is a risk of skin cancer developing. DP MP Gusty Graas has now been informed that these photos will no longer be reimbursed by health insurance. In a parliamentary question to the Minister of Health, the liberal politician would like to know, among other things, why this decision was made and how many patients have been reimbursed for such photos taken by dermatologists in the last five years.

read more...